NDC Pharmacologic Class N0000175657 CD20-directed Cytolytic Antibody [EPC]

  1. Home
  2. NDC Pharmacologic Class Index
  3. N0000175657
NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0069-0238Ruxience Rituximab-pvvrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-0249Ruxience Rituximab-pvvrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0078-0669Arzerra OfatumumabInjection, SolutionIntravenousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0690Arzerra OfatumumabInjection, SolutionIntravenousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-1007Kesimpta OfatumumabInjection, SolutionSubcutaneousNovartis Pharmaceuticals CorporationHuman Prescription Drug
50242-051Rituxan RituximabInjection, SolutionIntravenousGenentech, Inc.Human Prescription Drug
50242-053Rituxan RituximabInjection, SolutionIntravenousGenentech, Inc.Human Prescription Drug
50242-070Gazyva ObinutuzumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.Human Prescription Drug
50242-108Rituxan Hycela Rituximab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.Human Prescription Drug
50242-109Rituxan Hycela Rituximab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.Human Prescription Drug
50242-150Ocrevus OcrelizumabInjectionIntravenousGenentech, Inc.Human Prescription Drug
55513-224Riabni Rituximab-arrxInjection, SolutionIntravenousAmgen IncHuman Prescription Drug
55513-326Riabni Rituximab-arrxInjection, SolutionIntravenousAmgen IncHuman Prescription Drug
63459-103Truxima Rituximab-abbsInjection, SolutionIntravenousCephalon, Inc.Human Prescription Drug
63459-104Truxima Rituximab-abbsInjection, SolutionIntravenousCephalon, Inc.Human Prescription Drug

There are 15 NDC products with the pharmacologic class CD20-directed Cytolytic Antibody [EPC].